Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 296,683 | 282,021 | 228,122 | 211,822 | 222,503 |
| Marketable Securities | 86,644 | 93,527 | 76,430 | 65,852 | 57,812 |
| Receivables | 123,330 | 107,132 | 106,836 | 95,852 | 78,286 |
| Inventories | 24,887 | 24,021 | 22,941 | 22,418 | 22,403 |
| TOTAL | $549,684 | $530,575 | $453,398 | $410,818 | $392,788 |
| Non-Current Assets | |||||
| PPE Net | 1,862 | 1,277 | 1,177 | 1,108 | 1,139 |
| Investments And Advances | 8,105 | 2,470 | 17,112 | 20,912 | 12,526 |
| Intangibles | 260,921 | 231,895 | 237,870 | 243,845 | 249,819 |
| Other Non-Current Assets | 22,241 | 18,898 | 16,268 | 13,562 | 14,482 |
| TOTAL | $293,129 | $254,540 | $272,427 | $279,427 | $277,966 |
| Total Assets | $842,813 | $785,115 | $725,825 | $690,245 | $670,754 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,614 | 12,167 | 17,657 | 11,639 | 14,618 |
| Accrued Expenses | 196,185 | 148,192 | 127,139 | 115,938 | 111,933 |
| TOTAL | $205,799 | $160,359 | $144,796 | $127,577 | $126,551 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 322,324 | 332,710 | 325,871 | 329,412 | 318,563 |
| TOTAL | $322,324 | $332,710 | $325,871 | $329,412 | $318,563 |
| Total Liabilities | $528,123 | $493,069 | $470,667 | $456,989 | $445,114 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,342 | 51,394 | 50,238 | 49,535 | 49,014 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -667,544 | -661,814 | -664,719 | -658,858 | -644,181 |
| Other shareholders' equity | 351 | 37 | 352 | -258 | -373 |
| TOTAL | $314,690 | $292,046 | $255,158 | $233,256 | $225,640 |
| Total Liabilities And Equity | $842,813 | $785,115 | $725,825 | $690,245 | $670,754 |